WASHINGTON UNIVERSITY — MAZE THERAPEUTICS INC MAZE: Quarterly 13F Position History
WASHINGTON UNIVERSITY has reported MAZE THERAPEUTICS INC (MAZE) on 3 13F-HR filings in Pactolio's tracked window, first appearing in Q3 2025. As of Q1 2026, the position is sized at 280,802 shares ($8.4M market value, 5.23% of the equity book).
- 280,802Shares Held (Latest Filing)
- $8.4MReported Market Value (Latest Filing)
- 5.23%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- -$3.3MQuarter-over-Quarter Value Change
- 280,802Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 3 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 280,802 | 0 | — | $8.4M | 5.23% | $29.85 |
| Q4 2025 | 280,802 | +70,121 | +33.3% | $11.6M | 5.88% | $41.43 |
| Q3 2025 | 210,681 | — | — | $5.5M | 3.06% | $25.93 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did WASHINGTON UNIVERSITY first disclose a MAZE position in 13F-HR filings?
WASHINGTON UNIVERSITY first reported MAZE THERAPEUTICS INC (MAZE) on its 13F-HR filing for the period ending 2025-09-30 (Q3 2025). The position has appeared on 3 reported quarters within Pactolio's tracked window.
What was WASHINGTON UNIVERSITY's most recent quarter-over-quarter share-count change in MAZE?
WASHINGTON UNIVERSITY held the same 280,802 shares of MAZE between Q4 2025 and Q1 2026 — the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent WASHINGTON UNIVERSITY's cost basis in MAZE?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.